833-5 Markers of inflammation predict mortality and are reduced by pexelizumab in patients with acute myocardial infarction: Insights from the complement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
- 1 March 2004
- journal article
- abstracts
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 43 (5) , A287
- https://doi.org/10.1016/s0735-1097(04)91216-8
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: